Lactose (India) Limited (BSE: 524202)
Health Care · Pharmaceuticals · IN
Rs103.95
-1.38% today · -15.7% 1Y
Lactose (India) Limited (BSE: 524202) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $13.52M.
Over the last twelve months the share price has lost 15.7%, trading between 76.01 and 136.45.
Tweenvest scores Lactose (India) Limited across four factors: quality 55/100, value 77/100, growth 85/100. Its strongest factor is growth.
524202 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.52M
- Revenue (TTM)
- $18.05M
- P/E
- 19.31
- EPS
- 5.38
- Dividend yield
- —
- Beta (5Y)
- 0.76
- 52-week high
- Rs136.45
- 52-week low
- Rs76.01
- Avg volume (3M)
- —
- Shares outstanding
- 12.59M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Yi Po International Holding LimitedOTCPK: YBZN | $13.77M | $— | — |
| Tvardi Therapeutics, Inc.NasdaqCM: TVRD | $13.74M | $1.03 | 0.00% |
| WooGene B&G Co., LtdKOSDAQ: A018620 | $13.72M | ₩2,660.00 | -0.19% |
| Citius Pharmaceuticals, Inc.NasdaqCM: CTXR | $13.71M | $0.48 | -3.62% |
| PT Phapros TbkIDX: PEHA | $13.52M | Rp288.00 | +2.86% |
| Klaria Pharma Holding AB (publ.)OM: KLAR | $13.36M | Skr0.53 | -2.58% |
| Ayr Wellness Inc.CNSX: AYR.A | $13.21M | CA$— | — |
| Indo-Bangla Pharmaceuticals LimitedDSE: IBP | $13.02M | Tk13.80 | -5.48% |
Figures last refreshed Oct 11, 2026.